These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 12869284)

  • 1. The Ret proto-oncogene in the WAG/Rij rat strain: an animal model for inherited C-cell carcinoma?
    De Miguel M; Fernández-Santos JM; Trigo-Sánchez I; Matera I; Ceccherini I; Martín I; Romeo G; Galera-Davidson H
    Lab Anim; 2003 Jul; 37(3):215-21. PubMed ID: 12869284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic.
    Jindrichová S; Vcelák J; Vlcek P; Neradilová M; Nemec J; Bendlová B
    J Endocrinol; 2004 Nov; 183(2):257-65. PubMed ID: 15531714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
    Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline RET mutations in exons 10 and 11: an Iranian survey of 57 medullary thyroid carcinoma cases.
    Hedayati M; Nabipour I; Rezaei-Ghaleh N; Azizi F
    Med J Malaysia; 2006 Dec; 61(5):564-9. PubMed ID: 17623957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medullary thyroid carcinoma in a child with a new RET mutation and a RET polymorphism.
    Vandenbosch K; Renard M; Uyttebroeck A; Sciot R; Matthijs G; Legius E
    Genet Couns; 2005; 16(1):95-100. PubMed ID: 15844786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma].
    Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
    Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor].
    Amosenko FA; Brzhezovskiĭ VZh; Liubchenko LN; Shabanov MA; Kozlova VM; Vanushko VE; Kazubskaia TP; Gar'kavtseva RF; Kalinin VN
    Genetika; 2003 Jun; 39(6):847-54. PubMed ID: 12884527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population.
    Alvandi E; Akrami SM; Chiani M; Hedayati M; Nayer BN; Tehrani MR; Nakhjavani M; Pedram M
    Thyroid; 2011 Apr; 21(4):373-82. PubMed ID: 21309721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a DHPLC-based assay for rapid detection of RET germline mutations in Italian patients with medullary thyroid carcinoma.
    Torrente I; Arturi F; D'Aloiso L; Colosimo A; De Luca A; Ferretti E; Russo D; Chiefari E; Scarpelli D; Bisceglia M; Dallapiccola B; Filetti S
    J Endocrinol Invest; 2004 Feb; 27(2):111-6. PubMed ID: 15129804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of deletions of the RET proto-oncogene wtih aggressive course of sporatic C-cell carcinoma].
    Musholt PB; Musholt TJ; Moley JF; Scheumann GF
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):261-5. PubMed ID: 14518256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma.
    Wiench M; Włoch J; Wygoda Z; Gubała E; Oczko M; Pawlaczek A; Kula D; Lange D; Jarzab B
    Cancer Detect Prev; 2004; 28(4):231-6. PubMed ID: 15350625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.
    Wiench M; Wygoda Z; Gubala E; Wloch J; Lisowska K; Krassowski J; Scieglinska D; Fiszer-Kierzkowska A; Lange D; Kula D; Zeman M; Roskosz J; Kukulska A; Krawczyk Z; Jarzab B
    J Clin Oncol; 2001 Mar; 19(5):1374-80. PubMed ID: 11230481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis reveals novel sequence variants in NTRK1 in sporadic human medullary thyroid carcinoma.
    Gimm O; Greco A; Hoang-Vu C; Dralle H; Pierotti MA; Eng C
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2784-7. PubMed ID: 10443680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse model.
    Cranston AN; Ponder BA
    Cancer Res; 2003 Aug; 63(16):4777-80. PubMed ID: 12941793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic background of medullary thyroid carcinoma in young patients.
    Wiench M; Wygoda Z; Gubała E; Włoch J; Oczko M; Jarzab B
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():163-4. PubMed ID: 11820587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four novel RET germline variants in exons 8 and 11 display an oncogenic potential in vitro.
    Muzza M; Cordella D; Bombled J; Bressac-de Paillerets B; Guizzardi F; Francis Z; Beck-Peccoz P; Schlumberger M; Persani L; Fugazzola L
    Eur J Endocrinol; 2010 Apr; 162(4):771-7. PubMed ID: 20103606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does phaster mean better?
    Angrist M
    Clin Chem; 1997 Mar; 43(3):424-6. PubMed ID: 9068584
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutation analysis of NTRK2 and NTRK3, encoding 2 tyrosine kinase receptors, in sporadic human medullary thyroid carcinoma reveals novel sequence variants.
    Gimm O; Dziema H; Brown J; de la Puente A; Hoang-Vu C; Dralle H; Plass C; Eng C
    Int J Cancer; 2001 Apr; 92(1):70-4. PubMed ID: 11279608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of mutations in RET proto-oncogene codon 634 through double tandem hybridization.
    Maldonado-Rodríguez R; Espinosa-Lara M; Barrera-León O; Colin-Tovar C; González-Yebra B; Salcedo-Vargas M; Santiago-Hernández JC; Méndez-Tenorio A; Beattie KL
    Mol Biotechnol; 2003 Oct; 25(2):113-29. PubMed ID: 14526122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.